Avalo Therapeutics Inc

The current institutional shareholding score of Avalo Therapeutics Inc is 5.00, ranking 132 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 60.06%, representing a quarter-over-quarter increase of 20.42%. The largest institutional shareholder is Steven Cohen, holding a total of 866.37K shares, representing 3.72% of shares outstanding, with 27.87% decrease in holdings.